Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 81 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named S 43. Clear
Clear
Q3
GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Trade (domestic/foreign), Health Issues
View → Q3
SANOFI US SERVICES INC. for SANOFI US SERVICES INC
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Manufacturing, Health Issues, Medicare/Medicaid, Trade (domestic/foreign)
View → Q3
WHITMER & WORRALL, LLC for CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $50,000.00 income
Medicare/Medicaid, Copyright/Patent/Trademark, Pharmacy
View → Q3
ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Pharmacy, Medicare/Medicaid, Copyright/Patent/Trademark, Trade (domestic/foreign)
View → Q3
BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Homeland Security
View → Q3
NOVARTIS for NOVARTIS
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View → Q3
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Trade (domestic/foreign), Health Issues
View → Q3
MEHLMAN CONSULTING, INC. for ASSOCIATION OF ACCESSIBLE MEDICINES
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues, Pharmacy
View → Q3
FRESENIUS KABI USA LLC for FRESENIUS KABI USA LLC
3rd Quarter (July 1 - Sep 30) 2025 · Illinois · House · Senate
Manufacturing, Budget/Appropriations, Copyright/Patent/Trademark, Trade (domestic/foreign)
View → Q3
MEHLMAN CONSULTING, INC. for THE CAMPAIGN FOR SUSTAINABLE RX PRICING
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $90,000.00 income
Medicare/Medicaid, Pharmacy, Copyright/Patent/Trademark
View → Q3
APOTEX CORP. for APOTEX CORP.
3rd Quarter (July 1 - Sep 30) 2025 · Florida · House · Senate
Manufacturing, Health Issues, Tariff (miscellaneous tariff bills)
View → Q3
FIERCE GOVERNMENT RELATIONS for ASSOCIATION OF ACCESSIBLE MEDICINES (FORMERLY KNOWN AS GPHA)
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy
View → Q3
INTELLECTUAL PROPERTY OWNERS ASSOCIATION for INTELLECTUAL PROPERTY OWNERS ASSOCIATION
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Copyright/Patent/Trademark
View → Q2
SANOFI US SERVICES INC. for SANOFI US SERVICES INC
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Trade (domestic/foreign), Taxation/Internal Revenue Code
View → Q2
WHITMER & WORRALL, LLC for CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $50,000.00 income
Medicare/Medicaid, Copyright/Patent/Trademark, Pharmacy
View → Q2
GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View → Q2
FIERCE GOVERNMENT RELATIONS for ASSOCIATION OF ACCESSIBLE MEDICINES (FORMERLY KNOWN AS GPHA)
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy
View → Q2
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View → Q2
AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION (AIPLA) for AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION (AIPLA)
2nd Quarter (Apr 1 - June 30) 2025 · Virginia · House · Senate
Copyright/Patent/Trademark
View → Q2
MEHLMAN CONSULTING, INC. for THE CAMPAIGN FOR SUSTAINABLE RX PRICING
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $90,000.00 income
Medicare/Medicaid, Pharmacy, Copyright/Patent/Trademark
View → Q2
NOVARTIS for NOVARTIS
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View → Q2
ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Pharmacy, Medicare/Medicaid, Copyright/Patent/Trademark, Trade (domestic/foreign)
View → Q2
INTELLECTUAL PROPERTY OWNERS ASSOCIATION for INTELLECTUAL PROPERTY OWNERS ASSOCIATION
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Copyright/Patent/Trademark
View → 1A
GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Medicare/Medicaid, Copyright/Patent/Trademark, Health Issues
View → Q1
GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Previous Page 3 of 4 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem